{"transactions":[{"id":1860383,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-09T16:11:14.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":false,"shares":14607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on June 7, 2024."}],"balance_after":14607,"derivative":{"exercise_price":0.8264,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14607},"source":{"system":"sec-edgar","filing":"0001104659-23-069908","document":"tm2318251-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000110465923069908/tm2318251-5_4seq1.xml","form_type":"4"}},{"id":2015989,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-02-14T16:45:28.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":29000,"price":1.52,"value":44080.0,"ownership":{"direct":true},"balance_after":29000,"derivative":{"exercise_price":1.52,"exercise_date":"2024-02-10","expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001415889-23-002455","document":"form4-02142023_040202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000141588923002455/form4-02142023_040202.xml","form_type":"4"}},{"id":2448549,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-01-04T16:10:26.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":21828,"price":3.1,"value":67666.8,"ownership":{"direct":true},"balance_after":36966,"derivative":{"exercise_price":3.1,"exercise_date":"2022-12-31","expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":21828},"source":{"system":"sec-edgar","filing":"0001415889-22-000187","document":"form4-01042022_040110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000141588922000187/form4-01042022_040110.xml","form_type":"4"}},{"id":3032227,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-14T16:02:38.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":6509,"price":10.12,"value":65871.08,"ownership":{"direct":true},"balance_after":15138,"derivative":{"exercise_price":10.12,"exercise_date":"2021-09-10","expiration_date":"2030-09-10","underlying":"Common Stock","underlying_shares":6509},"source":{"system":"sec-edgar","filing":"0001600132-20-000099","document":"wf-form4_160011374518224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000160013220000099/wf-form4_160011374518224.xml","form_type":"4"}},{"id":3404353,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-30T16:51:21.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":46266,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":129482,"derivative":{"exercise_price":0.5,"exercise_date":"2020-09-26","expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":46266},"source":{"system":"sec-edgar","filing":"0001600132-19-000128","document":"wf-form4_156987665937588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000160013219000128/wf-form4_156987665937588.xml","form_type":"4"}},{"id":3901486,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T16:52:28.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":38216,"price":2.27,"value":86750.32,"ownership":{"direct":true},"balance_after":83216,"derivative":{"exercise_price":2.27,"exercise_date":"2019-06-05","expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":38216},"source":{"system":"sec-edgar","filing":"0001600132-18-000071","document":"wf-form4_152840473035562.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000160013218000071/wf-form4_152840473035562.xml","form_type":"4"}},{"id":4201468,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T16:59:58.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 22, 2017. This option vests in three equal annual installments over a three-year period from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":1.12,"expiration_date":"2027-09-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001600132-17-000103","document":"wf-form4_150645958329659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411721/000160013217000103/wf-form4_150645958329659.xml","form_type":"4"}},{"id":468743,"issuer":{"id":369,"kind":"organization","name":"STRYKER CORP","symbol":"SYK"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Med&Scientific Off."}}],"security":"Employee Stock Option granted 02/12/2014 (right to buy)","published_at":"2014-02-14T20:25:55.000Z","date":"2014-02-12","kind":"grant","acquired":true,"shares":18980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant."}],"balance_after":18980,"derivative":{"exercise_price":81.14,"expiration_date":"2024-02-11","underlying":"Common Stock","underlying_shares":18980},"source":{"system":"sec-edgar","filing":"0000310764-14-000036","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076414000036/edgar.xml","form_type":"4"}},{"id":481882,"issuer":{"id":369,"kind":"organization","name":"STRYKER CORP","symbol":"SYK"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Med&Scientific Off."}}],"security":"Restricted Stock Units granted 02/13/2013","published_at":"2013-02-15T22:14:17.000Z","date":"2013-02-13","kind":"grant","acquired":true,"shares":3906,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each retsricted stock unit represents a contingent right to receive one share of Stryker common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each retsricted stock unit represents a contingent right to receive one share of Stryker common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest as to 100% of the shares on February 13, 2016.  Vesting will be accelerated in the event of termination of employment by reason of disability or death but will otherwise cease upon termination of employment with Stryker."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest as to 100% of the shares on February 13, 2016.  Vesting will be accelerated in the event of termination of employment by reason of disability or death but will otherwise cease upon termination of employment with Stryker."}],"balance_after":3906,"derivative":{"underlying":"Common Stock","underlying_shares":3906},"source":{"system":"sec-edgar","filing":"0000310764-13-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076413000028/edgar.xml","form_type":"4"}},{"id":481881,"issuer":{"id":369,"kind":"organization","name":"STRYKER CORP","symbol":"SYK"},"owners":[{"id":16549,"kind":"person","name":"Bruder Scott P","position":1,"cik":"0001411721","reported_name":"Bruder Scott P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Med&Scientific Off."}}],"security":"Employee Stock Option granted 02/13/2013 (right to buy)","published_at":"2013-02-15T22:14:17.000Z","date":"2013-02-13","kind":"grant","acquired":true,"shares":23510,"price":64.01,"value":1504875.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant."}],"balance_after":23510,"derivative":{"exercise_price":64.01,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":23510},"source":{"system":"sec-edgar","filing":"0000310764-13-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076413000028/edgar.xml","form_type":"4"}}]}